William Blair downgraded Paragon 28 (FNA) to Market Perform from Outperform without a price target after the company entered into a definitive agreement for Zimmer Biomet to acquire all its outstanding shares for $13.00 in cash, corresponding to an equity value of approximately $1.1B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FNA: